Eczema, also known as atopic dermatitis (AD), is a chronic, relapsing, inflammatory skin disease characterized by intense itch, recurrent eczematous lesions, and a fluctuating course.^1,2 Statistics showed that up to 20% of children are affected by AD worldwide, while 15% of secondary school children in Hong Kong are reported to have the problem.^3,4 In addition, evidence has suggested the prevalence of AD in Asia is on the rise.² Although AD can be controlled through various proven strategies, optimizing AD management is still a challenge since certain situations, such as steroid phobia and poor patient compliance, could lead to treatment failure.⁴ In these regards, an algorithm for the topical AD treatment was developed and published in 2020 for use by the primary care physicians, pediatricians, and dermatologists in South and East Asia.² In the interviews with Omnihealth Practice, Dr. Luk, Chi-Kong David and Professor Hon, Kam-Lun Ellis, authors of the practical recommendations, discussed the difficulties in managing mild-to-moderate AD, and shared their views on improving treatment outcomes in these AD patients.

Eating disorders (EDs) are serious psychiatric illnesses with high rates of morbidity and mortality.¹ In recent years, a higher prevalence of EDs has been observed among children and adolescents. Traditionally, behaviorally focused therapies